Bottom line
What is MSERX's expense ratio?
MSERX's expense ratio is 1.3%, or about $130 a year on every $10,000 invested. That is more expensive than 77% of small-cap funds we track (median 0.99%). It has no front-end sales load. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Jul 1, 2026
MSERX fee table
| Net expense ratio | 1.3% |
|---|---|
| Gross expense ratio | 1.33% |
| Management fee | 0.8% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.28% |
| Fee waiver / reimbursement | -0.03% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 1, 2026
What MSERX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MSERX | $132 | $417 | $724 | $1,597 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.3% expense ratio costs roughly $70,100 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).